Discovery of novel molecular and biochemical predictors of response and outcome in diffuse large B-cell lymphoma
Discovery of Novel Molecular and Biochemical Predictors of Response and Outcome in Diffuse Large B-cell Lymphoma Diffuse large B-cell lymphoma (DLBCL) is the commonest form of non-Hodgkin lymphoma and responds to treatment with a 5-year overall survival (OS) of 40-50%. Predicting outcome using the b...
| Main Author: | |
|---|---|
| Published: |
Queen Mary, University of London
2009
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.510881 |